Literature DB >> 15857799

How to diagnose and treat secondary forms of vasculitis.

Raashid Ahmed Luqmani1, Sanjay Pathare, Tony Lee Kwok-Fai.   

Abstract

Vasculitis is considered to be secondary when it arises either in the context of a pre-existing connective tissue disease, as a result of direct infection with a limited range of organisms, especially viruses, or when it arises in response to exposure to a number of medications. Rheumatoid vasculitis is probably the most widely recognised form of secondary vasculitis, and in this article we review the incidence, clinical features and management of this condition. Infections may either trigger or cause some types of vasculitis. Drug therapy is a common cause of limited forms of vasculitis and may enhance our understanding of the mechanism of these diseases. The premature development of atherosclerosis in patients with existing connective tissue diseases or indeed primary vasculitis has been recognised for some time, and the underlying mechanisms are currently being studied. An appreciation of the complex and varied pathophysiology of secondary vasculitis may further our understanding of primary vasculitis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857799     DOI: 10.1016/j.berh.2004.11.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  6 in total

Review 1.  French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).

Authors:  Benjamin Terrier; Raphaël Darbon; Cécile-Audrey Durel; Eric Hachulla; Alexandre Karras; Hélène Maillard; Thomas Papo; Xavier Puechal; Grégory Pugnet; Thomas Quemeneur; Maxime Samson; Camille Taille; Loïc Guillevin
Journal:  Orphanet J Rare Dis       Date:  2020-12-29       Impact factor: 4.123

Review 2.  Diagnostic approach to patients with suspected vasculitis.

Authors:  E Suresh
Journal:  Postgrad Med J       Date:  2006-08       Impact factor: 2.401

Review 3.  An approach to the diagnosis and management of systemic vasculitis.

Authors:  A Miller; M Chan; A Wiik; S A Misbah; R A Luqmani
Journal:  Clin Exp Immunol       Date:  2010-01-12       Impact factor: 4.330

4.  Central nervous system involvement as a major manifestation of rheumatoid arthritis.

Authors:  M Zolcinski; S Bazan-Socha; G Zwolinska; J Musial
Journal:  Rheumatol Int       Date:  2007-08-10       Impact factor: 2.631

5.  Vasculitis Secondary to Pulmonary Bacterial Infection: A Case Report.

Authors:  Wangji Zhou; Wei Ye; Juhong Shi; Sanxi Ai; Xinlun Tian
Journal:  Diagnostics (Basel)       Date:  2022-03-22

Review 6.  CMR in inflammatory vasculitis.

Authors:  Subha V Raman; Ashish Aneja; Wael N Jarjour
Journal:  J Cardiovasc Magn Reson       Date:  2012-11-30       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.